Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells

Cyclin-dependent kinase 2 (CDK2) has been reported to be essential for cell proliferation in several human tumours and it has been suggested as an appropriate target to be considered in order to enhance the efficacy of treatment regimens based on the use of DNA damaging drugs. We evaluated the clini...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PLoS One
Hoofdauteurs: Vella, Serena, Tavanti, Elisa, Hattinger, Claudia Maria, Fanelli, Marilù, Versteeg, Rogier, Koster, Jan, Picci, Piero, Serra, Massimo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2016
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5127503/
https://ncbi.nlm.nih.gov/pubmed/27898692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166233
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items